Unlocking the Future of the Porcine Epidemic Diarrhea Vaccines Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
Analyzing the Growth Rate of the Porcine Epidemic Diarrhea Vaccines Market: What’s the Expected CAGR for the Next Decade?
The market for porcine epidemic diarrhea vaccines has experienced substantial growth in recent years, with the size projected to rise from $1.67 billion in 2024 to $1.8 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.0%. The surge observed in the historical period is a result of widespread vaccination drives, enhanced immunization programs (EPI), the utilization of disposable syringes, endeavors to eradicate diarrhea, and partnerships such as the global alliance for vaccines and immunization (GAVI).
Expectations are high for the porcine epidemic diarrhea vaccines market to experience significant expansion in the upcoming years, with projections suggesting a rise to $2.42 billion in 2029, representing a compound annual growth rate (CAGR) of 7.6%. This predicted growth during the projection period is credited to an increased focus on immunization programs, a wide-ranging vaccine development pipeline, growing pig populations, emphasis on cold chain management, and heightening awareness of the value of preventive health measures. Other anticipated trends during this period include ongoing innovations in vaccine delivery device technology, a shift towards needle-free solutions, progress in personalised medicine, an increasing preference for self-administered vaccines, along with improvements in animal healthcare systems and distribution networks.
How Are the key drivers expanding the growth of the Porcine Epidemic Diarrhea Vaccines Market?
The growth of the porcine epidemic diarrhea vaccine market is expected to be driven by the surge in pig farming. This agricultural practice entails the breeding, raising, management, marketing, and selling of domestic pigs, primarily for meat production. This growth in pig farming is fueled by higher global demand for pork products, advancements in breeding and management methods, innovative farming techniques, and the growth of markets for pork consumption. To prevent and manage contagion, porcine epidemic diarrhea (PED) vaccines are used in pig farming. These vaccines, administered either through injection or orally, are usually initiated during the sow’s gestation period to pass on passive immunity to the newborn piglets via colostrum. For example, data from the United States Department of Agriculture, a US government department, shows that in 2022, pork production in the US amounted to 40.6 billion pounds, a 1 percent rise from the previous year. Therefore, the surge in pig farming is propelling the porcine epidemic diarrhea vaccine market forward.
Request Your Free Porcine Epidemic Diarrhea Vaccines Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
What Are the Leading Organizations Impacting the Porcine Epidemic Diarrhea Vaccines Market’s Growth?
Major companies operating in the porcine epidemic diarrhea vaccines market are:
• Zoetis Inc._x000D_
• Merck Animal Health_x000D_
• Elanco Animal Health_x000D_
• Idexx Laboratories Inc._x000D_
• Bio-Rad Laboratories Inc._x000D_
What Are the Most Prominent Trends Driving Change in the Porcine Epidemic Diarrhea Vaccines Market?
Prominent firms in the porcine epidemic diarrhea vaccines market are coming up with ground-breaking products like the Porcine Parvovirus (PPV) vaccine to fortify their standing in the market. The PPV vaccine is a veterinary immunization developed to prevent PPV induced reproductive failure in pigs, a small non-enveloped virus that is associated with issues like infertility, stillbirths, mummified foetuses, and feeble piglets. For example, in March 2022, Boehringer Ingelheim, a pharmaceutical giant based in Germany, introduced the ReproCyc ParvoFLEX, a PPV vaccine. This novel vaccine is formulated to fight against reproductive failure in pigs due to PPV. What sets this launch apart is the advanced formulation and effectiveness of the vaccine that provide broad protection against PPV-induced reproductive issues, ensuring the well-being and productivity of pig herds.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Core Segments of the Porcine Epidemic Diarrhea Vaccines Market, and How Do They Contribute to Growth?
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
What Regions Are Leading the Charge in the Porcine Epidemic Diarrhea Vaccines Market?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Porcine Epidemic Diarrhea Vaccines Market Categorized and Defined in the Industry?
Porcine epidemic diarrhea (PED) vaccines are biological preparations developed to provide immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal disease in pigs. These vaccines are essential tools in preventing and controlling Porcine Epidemic Diarrhea, contributing to the health and productivity of pig populations and the economic stability of the swine industry.
Browse Through More Similar Reports By The Business Research Company:
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
